Bioinformatics -- the marriage of biology and information technology -- is changing the way scientists study disease and develop medicines, replacing hours of tedious laboratory work with a few mouse clicks.
But bioinformatics companies, which captured Wall Street's imagination in the late 1990s, are losing their luster with investors. For instance, shares of InforMax Inc., a Bethesda software maker, are trading near their all-time low.
Yet Stephen E. Lincoln, InforMax's chief scientific officer, is as bullish as ever on the future of the industry.
Full story can be found in the Washington Post, March 14, 2002.
Message posted by: Anthony W.I. Lo
Bookmark and Share this page (what is this?)
Social bookmarking allows users to save and categorise a personal collection of bookmarks and share them with others. This is different to using your own browser bookmarks which are available using the menus within your web browser.
Use the links below to share this article on the social bookmarking site of your choice.
Read more about social bookmarking at Wikipedia - Social Bookmarking